Free Press Release

FaceBook Page Twitter Feed
You are here: Home > Exclusive News > Health Point Inc. Improves Ischemia Treatment

Health Point Inc. Improves Ischemia Treatment

Posted Jan 20, 2015 by reginaldanderson
Health Point Inc. recently announced another important advance towards the treatment of chronic lower limb ischemia.

FOR IMMEDIATE RELEASE (Press Release) Jan 20, 2015 -- The advance is radically different from the clinical treatment approach, which causes modified stem cells to be transplanted locally. Through Health Point's advancements in promoting angiogenesis within a laboratory setting, stem cells can now be activated to produce and stimulate new capillaries.

By increasing research funding for leading testing and treatment techniques, such as the study of mesenchymal stem cells from bone marrow, the company expects to learn crucial information about their immune modulatory properties. Research facility and staff expansion will be funded by the upcoming IPO. Contact your investment professional for moire information

Health Point Inc. (HPI) is a privately-owned company specializing in the development, manufacture and supply of stem cells for basic research and therapeutic development for the treatment of various diseases and conditions. The company utilizes what it calls Creative (stem cell-based) technology and other developed proprietary methods in the field of regenerative medicine that would enable drug discovery and life-changing therapies. More information can be found at

Health Point Inc. is committed to deliver safe, effective and affordable stem cell therapies in a bench-to-bed approach, by nurturing cutting-edge research and clinical applications and by matching customer satisfaction in attaining the rejuvenating hope. Health Point Inc. strives to maintain scientific and ethical practices through a Quality Management System in accordance with accepted national and international norms. Health Point Inc. will accomplish this through dedicated efforts of its team to continually monitor and improve the effectiveness of the Quality Management System to excel and innovate thereby reflecting that we are truly pro-Life.

The information contained in this release is provided on an errors and omissions excepted basis. No statements contained within are to be construed as an offer for sale of share capital or any other offer contrary to securities law. Information is current at time of publishing. Health Point Inc. cannot be held responsible for out of date or changing information. It is the responsibility of the reader to seek out up to date company information at and other sources before making any material decisions.
-- EOF ---
Contact Email :
Issued By : Reginald Anderson
Phone : 85281930750
Business Address : 15/F Millennium City 5 (APM)
418 Kwun Tong Rd Central, Hong Kong
Country : China
Categories : Business
Tags : health, Stem Cells, Research, Manufacture, Supply, Investment
Last Updated : Jan 20, 2015

New Press News

blog comments powered by Disqus
Popular TagsMore